Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
Crossref DOI link: https://doi.org/10.1038/s41569-022-00756-z
Published Online: 2022-09-01
Published Print: 2023-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kamel, Rima
Leroy, Jérôme
Vandecasteele, Grégoire
Fischmeister, Rodolphe https://orcid.org/0000-0003-2086-9865
Text and Data Mining valid from 2022-09-01
Version of Record valid from 2022-09-01
Article History
Accepted: 11 July 2022
First Online: 1 September 2022
Competing interests
: The authors declare no competing interests.